Position in OVID
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$85,542
New position
Shares Held
31,800
first reported quarter
Ownership
0.016%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#77
of 130 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Spark Investment Management LLC holds $1,642,942 across 22 Biotechnology names. OVID ranks #6 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYTX |
Kyverna Therapeutics, Inc.
|
25,100 | $223,641 | |
| 2 | CLYM |
Climb Bio, Inc.
|
13,600 | $177,344 | |
| 3 | ARTV |
Artiva Biotherapeutics, Inc.
|
16,500 | $160,050 | |
| 4 | IPSC |
Century Therapeutics, Inc.
|
59,000 | $144,550 | |
| 5 | PBYI |
Puma Biotechnology, Inc.
|
17,000 | $137,870 | |
| 6 | OVID |
Ovid Therapeutics Inc.
This page
|
31,800 | $85,542 | |
| 7 | MGNX |
Macrogenics Inc
|
17,200 | $79,464 | |
| 8 | AVIR |
Atea Pharmaceuticals, Inc.
|
16,200 | $75,330 |
All Filings in OVID
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,542 | 31,800 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||